Vault-13

PERCEPTIVE ADVISORS LLC

NEW YORK, NY · CIK 1224962 · 13F filing filed 2026-08-14

SEC-registered investment adviser since 2010 · limited liability company

As an employer

Where they work

people there (dot area)number not reportedmain officeHover or tap a dot. Australian and UK companies are placed at their business or registered address, with their staff across the whole country.

Offices

From Form ADV: the main office and the other offices where it does advisory work (at most the 25 largest), with the people doing investment work at each. “About” is worked out: the firm's investment staff less its other offices. Each city links to the other managers there.

CityCountryPeople
New York, NY (main office)United States United Statesabout 25
Greenwich, CTUnited States United States1
Miami Beach, FLUnited States United States1
Sheridan, WYUnited States United States1
Water Mill, NYUnited States United States

Map: places from GeoNames (CC BY 4.0), outlines from Natural Earth.

$6.4bn reported value +27.2% vs Q1 2026
102positions
48.9%in top 10
23 new 30 added 26 reduced 13 sold out vs Q1 2026

Options: 1 call positions ($24.1m notional), 6 put positions ($197.2m notional) – listed below, not included above.

Holdings, Q2 2026

The small lines show how much was held over the last 4 quarters (adjusted for stock splits).

#SecurityTickerShares Value% of portfolioChangeShares change
1 PRAXIS PRECISION MEDICINES I COM NEW PRAX PRAX 2,035,986 $681.6m10.58% 10.58% UnchangedShares held: Q3 2025 1.6m, Q4 2025 2.0m, Q1 2026 2.0m, Q2 2026 2.0m
2 SPYRE THERAPEUTICS INC COM NEW SYRE SYRE 4,319,496 $383.5m5.95% 5.95% AddedShares held: Q3 2025 1.2m, Q4 2025 3.1m, Q1 2026 3.8m, Q2 2026 4.3m +536.3k +536,271 14.2%
3 CELCUITY INC COM CELC CELC 3,197,200 $334.5m5.19% 5.19% AddedShares held: Q3 2025 3.0m, Q4 2025 3.2m, Q1 2026 3.1m, Q2 2026 3.2m +70.0k +70,000 2.2%
4 ASCENDIS PHARMA A/S ORD SHS ASND ASND 1,163,721 $310.4m4.82% 4.82% NewShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 1.2m
5 RHYTHM PHARMACEUTICALS INC COM RYTM RYTM 2,586,295 $287.2m4.46% 4.46% AddedShares held: Q3 2025 2.4m, Q4 2025 2.5m, Q1 2026 2.4m, Q2 2026 2.6m +212.5k +212,500 8.9%
6 ROIVANT SCIENCES LTD SHS ROIV ROIV 8,085,461 $286.1m4.44% 4.44% ReducedShares held: Q3 2025 7.4m, Q4 2025 8.0m, Q1 2026 8.3m, Q2 2026 8.1m -200.0k -200,000 -2.4%
7 RELAY THERAPEUTICS INC COM RLAY RLAY 14,106,187 $263.9m4.10% 4.10% AddedShares held: Q3 2025 0, Q4 2025 1.9m, Q1 2026 9.8m, Q2 2026 14.1m +4.4m +4,355,046 44.7%
8 TRAVERE THERAPEUTICS INC COM TVTX TVTX 3,752,574 $213.2m3.31% 3.31% ReducedShares held: Q3 2025 3.8m, Q4 2025 4.3m, Q1 2026 4.1m, Q2 2026 3.8m -390.0k -389,977 -9.4%
9 KARDIGAN INC COM KARD KARD 8,200,662 $195.6m3.04% 3.04% NewShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 8.2m
10 NUVALENT INC COM COM 1,580,505 $195.2m3.03% 3.03% UnchangedShares held: Q3 2025 1.6m, Q4 2025 1.7m, Q1 2026 1.6m, Q2 2026 1.6m
11 EDGEWISE THERAPEUTICS INC COM EWTX EWTX 4,373,974 $177.7m2.76% 2.76% ReducedShares held: Q3 2025 3.8m, Q4 2025 4.5m, Q1 2026 4.4m, Q2 2026 4.4m -50.0k -50,000 -1.1%
12 APOGEE THERAPEUTICS INC COM COM 1,308,113 $173.6m2.70% 2.70% ReducedShares held: Q3 2025 1.4m, Q4 2025 2.3m, Q1 2026 1.5m, Q2 2026 1.3m -232.3k -232,271 -15.1%
13 AMYLYX PHARMACEUTICALS INC COM AMLX AMLX 8,334,882 $149.7m2.32% 2.32% AddedShares held: Q3 2025 9.0m, Q4 2025 8.3m, Q1 2026 8.3m, Q2 2026 8.3m +50.0k +50,000 0.6%
14 MEIRAGTX HLDGS PLC COM MGTX MGTX 10,786,658 $145.7m2.26% 2.26% AddedShares held: Q3 2025 12.6m, Q4 2025 10.3m, Q1 2026 10.3m, Q2 2026 10.8m +460.6k +460,555 4.5%
15 ORUKA THERAPEUTICS INC COM ORKA ORKA 1,345,063 $128.0m1.99% 1.99% ReducedShares held: Q3 2025 1.3m, Q4 2025 1.5m, Q1 2026 1.4m, Q2 2026 1.3m -50.4k -50,438 -3.6%
16 INHIBRX BIOSCIENCES INC COM INBX INBX 1,297,763 $123.0m1.91% 1.91% ReducedShares held: Q3 2025 1.3m, Q4 2025 1.5m, Q1 2026 1.4m, Q2 2026 1.3m -144.9k -144,944 -10.1%
17 PROTAGONIST THERAPEUTICS INC COM PTGX PTGX 981,879 $120.4m1.87% 1.87% ReducedShares held: Q3 2025 1.0m, Q4 2025 1.4m, Q1 2026 1.2m, Q2 2026 981.9k -249.0k -249,000 -20.2%
18 SOLID BIOSCIENCES INC COM NEW SLDB SLDB 11,906,646 $118.9m1.85% 1.85% UnchangedShares held: Q3 2025 11.8m, Q4 2025 11.8m, Q1 2026 11.9m, Q2 2026 11.9m
19 ZYMEWORKS INC COM ZYME ZYME 4,182,953 $109.3m1.70% 1.70% AddedShares held: Q3 2025 2.1m, Q4 2025 3.3m, Q1 2026 3.5m, Q2 2026 4.2m +672.9k +672,875 19.2%
20 TANGO THERAPEUTICS INC COM TNGX TNGX 3,377,000 $105.6m1.64% 1.64% AddedShares held: Q3 2025 0, Q4 2025 513.0k, Q1 2026 808.2k, Q2 2026 3.4m +2.6m +2,568,847 317.9%
21 IMMATICS N.V SHS IMTX IMTX 10,383,456 $105.2m1.63% 1.63% UnchangedShares held: Q3 2025 9.4m, Q4 2025 10.4m, Q1 2026 10.4m, Q2 2026 10.4m
22 NURIX THERAPEUTICS INC COM NRIX NRIX 4,320,422 $104.8m1.63% 1.63% AddedShares held: Q3 2025 1.4m, Q4 2025 3.6m, Q1 2026 3.7m, Q2 2026 4.3m +609.5k +609,545 16.4%
23 BIOCRYST PHARMACEUTICALS INC COM BCRX BCRX 10,308,888 $103.1m1.60% 1.60% AddedShares held: Q3 2025 0, Q4 2025 3.2m, Q1 2026 7.4m, Q2 2026 10.3m +2.9m +2,874,855 38.7%
24 REVOLUTION MEDICINES INC COM RVMD RVMD 527,600 $98.8m1.53% 1.53% AddedShares held: Q3 2025 0, Q4 2025 0, Q1 2026 258.6k, Q2 2026 527.6k +269.0k +269,000 104.0%
25 AVALYN PHARMACEUTICALS INC COM SHS AVLN AVLN 2,675,296 $88.1m1.37% 1.37% NewShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 2.7m
26 DYNE THERAPEUTICS INC COM DYN DYN 2,689,235 $59.7m0.93% 0.93% ReducedShares held: Q3 2025 540.4k, Q4 2025 3.5m, Q1 2026 4.7m, Q2 2026 2.7m -2.0m -1,979,604 -42.4%
27 BIOGEN INC COM BIIB BIIB 276,173 $59.7m0.93% 0.93% NewShares held: Q3 2025 0, Q4 2025 124.0k, Q1 2026 0, Q2 2026 276.2k
28 IMMUNOVANT INC COM IMVT IMVT 1,357,383 $52.3m0.81% 0.81% ReducedShares held: Q3 2025 1.6m, Q4 2025 2.0m, Q1 2026 1.6m, Q2 2026 1.4m -240.0k -240,000 -15.0%
29 UNITEDHEALTH GROUP INC COM UNH UNH 116,806 $48.5m0.75% 0.75% NewShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 116.8k
30 IONIS PHARMACEUTICALS INC COM IONS IONS 566,000 $44.9m0.70% 0.70% AddedShares held: Q3 2025 0, Q4 2025 0, Q1 2026 504.0k, Q2 2026 566.0k +62.0k +62,000 12.3%
31 SUTRO BIOPHARMA INC COM SHS STRO STRO 1,304,846 $43.3m0.67% 0.67% AddedShares held: Q3 2025 0, Q4 2025 0, Q1 2026 715.3k, Q2 2026 1.3m +589.5k +589,539 82.4%
32 ALTO NEUROSCIENCE INC COM SHS ANRO ANRO 1,609,893 $42.5m0.66% 0.66% ReducedShares held: Q3 2025 155.4k, Q4 2025 1.8m, Q1 2026 2.0m, Q2 2026 1.6m -400.0k -400,000 -19.9%
33 JAZZ PHARMACEUTICALS PLC SHS USD JAZZ JAZZ 170,000 $41.0m0.64% 0.64% UnchangedShares held: Q3 2025 0, Q4 2025 170.0k, Q1 2026 170.0k, Q2 2026 170.0k
34 CORVUS PHARMACEUTICALS INC COM CRVS CRVS 2,667,441 $39.9m0.62% 0.62% AddedShares held: Q3 2025 1.4m, Q4 2025 692.4k, Q1 2026 2.3m, Q2 2026 2.7m +375.0k +375,000 16.4%
35 SIONNA THERAPEUTICS INC COM SION SION 905,000 $39.8m0.62% 0.62% AddedShares held: Q3 2025 1.2m, Q4 2025 1.2m, Q1 2026 658.4k, Q2 2026 905.0k +246.6k +246,561 37.5%
36 CYTOMX THERAPEUTICS INC COM CTMX CTMX 10,439,185 $39.1m0.61% 0.61% AddedShares held: Q3 2025 9.7m, Q4 2025 9.7m, Q1 2026 10.1m, Q2 2026 10.4m +340.4k +340,361 3.4%
37 ARTIVION INC COM AORT AORT 1,737,290 $39.0m0.61% 0.61% AddedShares held: Q3 2025 2.0m, Q4 2025 1.7m, Q1 2026 1.6m, Q2 2026 1.7m +100.0k +100,000 6.1%
38 X4 PHARMACEUTICALS INC COM NEW XFOR XFOR 7,933,491 $37.0m0.58% 0.58% AddedShares held: Q3 2025 0, Q4 2025 6.3m, Q1 2026 6.7m, Q2 2026 7.9m +1.2m +1,195,843 17.8%
39 CORCEPT THERAPEUTICS INC COM CORT CORT 398,385 $34.6m0.54% 0.54% AddedShares held: Q3 2025 0, Q4 2025 0, Q1 2026 50.0k, Q2 2026 398.4k +348.4k +348,385 696.8%
40 REPLIGEN CORP COM RGEN RGEN 248,212 $33.9m0.53% 0.53% ReducedShares held: Q3 2025 270.4k, Q4 2025 315.5k, Q1 2026 280.5k, Q2 2026 248.2k -32.3k -32,329 -11.5%
41 ANTERIS TECHNOLOGIES GLOBAL COM AVR AVR 3,425,476 $33.7m0.52% 0.52% UnchangedShares held: Q3 2025 1.7m, Q4 2025 1.7m, Q1 2026 3.4m, Q2 2026 3.4m
42 RAPPORT THERAPEUTICS INC COM RAPP RAPP 773,342 $32.2m0.50% 0.50% AddedShares held: Q3 2025 403.9k, Q4 2025 673.9k, Q1 2026 673.9k, Q2 2026 773.3k +99.4k +99,419 14.8%
43 DAMORA THERAPEUTICS INC COM NEW COM NEW 1,223,000 $31.8m0.49% 0.49% UnchangedShares held: Q3 2025 0, Q4 2025 0, Q1 2026 1.2m, Q2 2026 1.2m
44 CHARLES RIV LABS INTL INC COM CRL CRL 140,000 $31.8m0.49% 0.49% NewShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 140.0k
45 AXSOME THERAPEUTICS INC COM AXSM AXSM 118,450 $29.0m0.45% 0.45% ReducedShares held: Q3 2025 148.9k, Q4 2025 148.9k, Q1 2026 149.9k, Q2 2026 118.5k -31.5k -31,500 -21.0%
46 DBV TECHNOLOGIES S A SPONSORED ADS DBVT DBVT 1,653,350 $27.1m0.42% 0.42% AddedShares held: Q3 2025 0, Q4 2025 0, Q1 2026 964.4k, Q2 2026 1.7m +689.0k +688,959 71.4%
47 IRHYTHM TECHNOLOGIES INC COM IRTC IRTC 223,766 $26.6m0.41% 0.41% AddedShares held: Q3 2025 123.0k, Q4 2025 108.0k, Q1 2026 105.0k, Q2 2026 223.8k +118.7k +118,740 113.1%
48 ADAPTIVE BIOTECHNOLOGIES COR COM ADPT ADPT 1,217,325 $26.1m0.41% 0.41% AddedShares held: Q3 2025 0, Q4 2025 0, Q1 2026 152.5k, Q2 2026 1.2m +1.1m +1,064,825 698.2%
49 SAB BIOTHERAPEUTICS INC COM NEW SABS SABS 6,627,501 $25.8m0.40% 0.40% AddedShares held: Q3 2025 0, Q4 2025 803.2k, Q1 2026 6.4m, Q2 2026 6.6m +195.8k +195,758 3.0%
50 DANAHER CORPORATION COM DHR DHR 130,000 $24.8m0.38% 0.38% NewShares held: Q3 2025 0, Q4 2025 200.0k, Q1 2026 0, Q2 2026 130.0k
51 TENAX THERAPEUTICS INC COM NEW TENX TENX 1,700,000 $24.7m0.38% 0.38% AddedShares held: Q3 2025 0, Q4 2025 439.1k, Q1 2026 1.4m, Q2 2026 1.7m +252.2k +252,218 17.4%
52 NAUTILUS BIOTECHNOLOGY INC COM NAUT NAUT 11,634,211 $21.8m0.34% 0.34% ReducedShares held: Q3 2025 12.6m, Q4 2025 12.6m, Q1 2026 12.6m, Q2 2026 11.6m -960.0k -960,000 -7.6%
53 ORCHESTRA BIOMED HLDGS INC COM OBIO OBIO 5,037,906 $21.7m0.34% 0.34% UnchangedShares held: Q3 2025 5.3m, Q4 2025 5.1m, Q1 2026 5.0m, Q2 2026 5.0m
54 INTUITIVE SURGICAL INC COM NEW ISRG ISRG 51,884 $20.6m0.32% 0.32% ReducedShares held: Q3 2025 52.1k, Q4 2025 87.9k, Q1 2026 85.4k, Q2 2026 51.9k -33.5k -33,535 -39.3%
55 ADLAI NORTYE LTD SPONSORED ADS ANL ANL 1,793,190 $20.6m0.32% 0.32% NewShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 1.8m
56 CONTINEUM THERAPEUTICS INC CL A CTNM CTNM 1,255,592 $20.6m0.32% 0.32% UnchangedShares held: Q3 2025 714.6k, Q4 2025 1.5m, Q1 2026 1.3m, Q2 2026 1.3m
57 NUVECTIS PHARMA INC COM NVCT NVCT 1,000,000 $18.4m0.29% 0.29% NewShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 1.0m
58 PALISADE BIO INC COM PALI PALI 8,425,065 $17.6m0.27% 0.27% ReducedShares held: Q3 2025 0, Q4 2025 12.1m, Q1 2026 8.9m, Q2 2026 8.4m -503.1k -503,084 -5.6%
59 OMADA HEALTH INC COM OMDA OMDA 786,330 $17.3m0.27% 0.27% UnchangedShares held: Q3 2025 2.4m, Q4 2025 2.4m, Q1 2026 786.3k, Q2 2026 786.3k
60 LEONABIO INC COM LONA LONA 1,859,322 $17.1m0.27% 0.27% UnchangedShares held: Q3 2025 540.3k, Q4 2025 1.9m, Q1 2026 1.9m, Q2 2026 1.9m
61 EVOLUS INC COM EOLS EOLS 2,459,285 $17.1m0.27% 0.27% AddedShares held: Q3 2025 0, Q4 2025 0, Q1 2026 1.3m, Q2 2026 2.5m +1.2m +1,172,423 91.1%
62 INVIVYD INC COM IVVD IVVD 18,490,636 $16.1m0.25% 0.25% ReducedShares held: Q3 2025 0, Q4 2025 21.8m, Q1 2026 20.9m, Q2 2026 18.5m -2.4m -2,368,667 -11.4%
63 CELCUITY INC NOTE 2.750% 8/0 · principal CELC 2.75 08.01.31 · principal CELC 2.75 08.01.31 6,500,000 $14.6m0.23% 0.23% UnchangedPrincipal held: Q3 2025 6.5m, Q4 2025 6.5m, Q1 2026 6.5m, Q2 2026 6.5m
64 MIRUM PHARMACEUTICALS INC COM MIRM MIRM 115,391 $13.5m0.21% 0.21% NewShares held: Q3 2025 0, Q4 2025 259.5k, Q1 2026 0, Q2 2026 115.4k
65 SURROZEN INC COM NEW SRZN SRZN 503,985 $13.1m0.20% 0.20% AddedShares held: Q3 2025 0, Q4 2025 0, Q1 2026 229.4k, Q2 2026 504.0k +274.6k +274,592 119.7%
66 BETA BIONICS INC COM BBNX BBNX 832,944 $13.1m0.20% 0.20% ReducedShares held: Q3 2025 277.9k, Q4 2025 602.9k, Q1 2026 842.9k, Q2 2026 832.9k -10.0k -10,000 -1.2%
67 AXOGEN INC COM AXGN AXGN 247,312 $11.4m0.18% 0.18% ReducedShares held: Q3 2025 0, Q4 2025 784.1k, Q1 2026 697.3k, Q2 2026 247.3k -450.0k -450,000 -64.5%
68 OSCAR HEALTH INC CL A OSCR OSCR 400,000 $11.4m0.18% 0.18% NewShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 400.0k
69 OCULIS HOLDING AG ORDINARY SHARES OCS OCS 808,827 $11.2m0.17% 0.17% AddedShares held: Q3 2025 0, Q4 2025 493.8k, Q1 2026 493.8k, Q2 2026 808.8k +315.0k +315,000 63.8%
70 SEAPORT THERAPEUTICS INC COMMON STOCK SPTX SPTX 500,000 $10.9m0.17% 0.17% NewShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 500.0k
71 VIRIDIAN THERAPEUTICS INC COM VRDN VRDN 581,980 $10.7m0.17% 0.17% ReducedShares held: Q3 2025 1.5m, Q4 2025 3.0m, Q1 2026 1.2m, Q2 2026 582.0k -588.8k -588,849 -50.3%
72 BOSTON SCIENTIFIC CORP COM BSX BSX 250,000 $10.7m0.17% 0.17% NewShares held: Q3 2025 310.0k, Q4 2025 979.0k, Q1 2026 0, Q2 2026 250.0k
73 BILLIONTOONE INC CL A BLLN BLLN 86,812 $10.4m0.16% 0.16% ReducedShares held: Q3 2025 0, Q4 2025 72.8k, Q1 2026 91.8k, Q2 2026 86.8k -5.0k -5,000 -5.5%
74 ABIVAX SA SPONSORED ADS ABVX ABVX 74,000 $9.9m0.15% 0.15% ReducedShares held: Q3 2025 388.6k, Q4 2025 458.3k, Q1 2026 328.9k, Q2 2026 74.0k -254.9k -254,884 -77.5%
75 NATERA INC COM NTRA NTRA 34,689 $9.4m0.15% 0.15% NewShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 34.7k
76 ENGENE THERAPEUTICS INC COM ENGN ENGN 4,822,169 $8.3m0.13% 0.13% NewShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 4.8m
77 RESEARCH ALLIANCE CORP III ORD SHS CL A RACC RACC 750,000 $8.0m0.12% 0.12% NewShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 750.0k
78 AGOMAB THERAPEUTICS NV SPONSORED ADS AGMB AGMB 600,000 $7.8m0.12% 0.12% UnchangedShares held: Q3 2025 0, Q4 2025 0, Q1 2026 600.0k, Q2 2026 600.0k
79 CULLINAN THERAPEUTICS INC COM CGEM CGEM 426,478 $7.8m0.12% 0.12% NewShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 426.5k
80 UNIQURE NV SHS QURE QURE 168,000 $7.7m0.12% 0.12% NewShares held: Q3 2025 20.0k, Q4 2025 0, Q1 2026 0, Q2 2026 168.0k
81 MOBIA MED INC COMMON STOCK MOBI MOBI 523,654 $7.0m0.11% 0.11% NewShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 523.7k
82 ADAGIO MED HLDGS INC COM ADGM ADGM 9,876,586 $6.4m0.10% 0.10% AddedShares held: Q3 2025 9.9m, Q4 2025 9.9m, Q1 2026 9.9m, Q2 2026 9.9m +10 +10 0.0%
83 GUARDANT HEALTH INC COM GH GH 41,327 $6.2m0.10% 0.10% ReducedShares held: Q3 2025 0, Q4 2025 160.0k, Q1 2026 300.0k, Q2 2026 41.3k -258.7k -258,673 -86.2%
84 PHATHOM PHARMACEUTICALS INC COM PHAT PHAT 532,000 $5.8m0.09% 0.09% ReducedShares held: Q3 2025 0, Q4 2025 0, Q1 2026 925.0k, Q2 2026 532.0k -393.0k -393,000 -42.5%
85 OUTLOOK THERAPEUTICS INC COM OTLK OTLK 3,139,216 $5.0m0.08% 0.08% NewShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 3.1m
86 COGENT BIOSCIENCES INC COM COGT COGT 121,082 $4.7m0.07% 0.07% UnchangedShares held: Q3 2025 0, Q4 2025 121.1k, Q1 2026 121.1k, Q2 2026 121.1k
87 EDESA BIOTECH INC COM NEW EDSA EDSA 563,239 $4.6m0.07% 0.07% UnchangedShares held: Q3 2025 0, Q4 2025 0, Q1 2026 563.2k, Q2 2026 563.2k
88 AVALO THERAPEUTICS INC COM NEW AVTX AVTX 219,813 $4.1m0.06% 0.06% AddedShares held: Q3 2025 139.7k, Q4 2025 139.7k, Q1 2026 139.7k, Q2 2026 219.8k +80.1k +80,146 57.4%
89 TWIST BIOSCIENCE CORP COM TWST TWST 36,812 $3.8m0.06% 0.06% ReducedShares held: Q3 2025 0, Q4 2025 0, Q1 2026 150.0k, Q2 2026 36.8k -113.2k -113,188 -75.5%
90 CRESCENT BIOPHARMA INC. COM CBIO CBIO 206,942 $3.7m0.06% 0.06% UnchangedShares held: Q3 2025 453.7k, Q4 2025 453.7k, Q1 2026 206.9k, Q2 2026 206.9k
91 XERIS BIOPHARMA HOLDINGS INC COM XERS XERS 467,013 $3.7m0.06% 0.06% NewShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 467.0k
92 OUTSET MED INC COM NEW OM OM 833,333 $3.6m0.06% 0.06% UnchangedShares held: Q3 2025 833.3k, Q4 2025 833.3k, Q1 2026 833.3k, Q2 2026 833.3k
93 BIODESIX INC COM BDSX BDSX 108,694 $2.5m0.04% 0.04% NewShares held: Q3 2025 108.7k, Q4 2025 108.7k, Q1 2026 0, Q2 2026 108.7k
94 REVOLUTION MEDICINES INC *W EXP 12/17/202 RVMDW RVMDW 250,000 $2.3m0.04% 0.04% UnchangedShares held: Q3 2025 250.0k, Q4 2025 250.0k, Q1 2026 250.0k, Q2 2026 250.0k
95 CONNECT BIOPHARMA HLDGS LTD SHS CNTB CNTB 792,696 $1.9m0.03% 0.03% UnchangedShares held: Q3 2025 0, Q4 2025 792.7k, Q1 2026 792.7k, Q2 2026 792.7k
96 KIORA PHARMACEUTICALS INC COM KPRX KPRX 438,471 $1.2m0.02% 0.02% NewShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 438.5k
97 MEDLINE INC COM CL A MDLN MDLN 28,000 $1.1m0.02% 0.02% UnchangedShares held: Q3 2025 0, Q4 2025 28.0k, Q1 2026 28.0k, Q2 2026 28.0k
98 ADMA BIOLOGICS INC COM ADMA ADMA 113,765 $952.2k0.01% 0.01% ReducedShares held: Q3 2025 1.2m, Q4 2025 883.5k, Q1 2026 467.2k, Q2 2026 113.8k -353.5k -353,468 -75.7%
99 CUMBERLAND PHARMACEUTICALS I COM CPIX CPIX 96,982 $628.4k0.01% 0.01% ReducedShares held: Q3 2025 0, Q4 2025 341.1k, Q1 2026 197.0k, Q2 2026 97.0k -100.0k -99,996 -50.8%
100 EXAGEN INC COM XGN XGN 114,893 $534.3k0.01% 0.01% UnchangedShares held: Q3 2025 0, Q4 2025 0, Q1 2026 114.9k, Q2 2026 114.9k

Sold out since Q1 2026

SecurityTickerShares held beforeValue then
ASCENDIS PHARMA A/S 1,531,421 $350.3m1.5m shares
CENTESSA PHARMACEUTICALS PLC 5,258,903 $208.9m5.3m shares
ENGENE HOLDINGS INC 5,827,506 $39.7m5.8m shares
DAY ONE BIOPHARMACEUTICALS I 1,755,799 $37.6m1.8m shares
BRIGHT MINDS BIOSCIENCES INC DRUG DRUG 377,544 $27.5m377.5k shares
BELITE BIO INC BLTE BLTE 151,979 $24.2m152.0k shares
EVOMMUNE INC EVMN EVMN 448,350 $10.3m448.4k shares
NEUMORA THERAPEUTICS INC. NMRA NMRA 5,104,097 $10.0m5.1m shares
NEUROCRINE BIOSCIENCES INC NBIX NBIX 65,050 $8.6m65.0k shares
OPUS GENETICS INC IRD IRD 1,835,842 $8.4m1.8m shares
INHIBIKASE THERAPEUTICS INC IKT IKT 2,315,000 $3.9m2.3m shares
APELLIS PHARMACEUTICALS INC APLS APLS 80,956 $3.3m81.0k shares
PALATIN TECHNOLOGIES INC PTN PTN 61,945 $1.1m61.9k shares

Options (notional value)

UnderlyingTickerTypeShares controlled NotionalChange
MODERNA INC MRNA · Put MRNAPut 1,000,000 $70.0m1.0m shares Unchanged
SPDR SER TR XBI · Put XBIPut 300,000 $47.5m300.0k shares New
EYEPOINT PHARMACEUTICALS INC EYPT · Put EYPTPut 2,000,000 $28.6m2.0m shares New
CAPRICOR THERAPEUTICS INC CAPR · Call CAPRCall 1,000,000 $24.1m1.0m shares New
SELLAS LIFE SCIENCES GROUP I SLS · Put SLSPut 1,500,000 $22.1m1.5m shares New
NEWAMSTERDAM PHARMA COMPANY NAMS · Put NAMSPut 500,000 $16.9m500.0k shares New
CAPRICOR THERAPEUTICS INC CAPR · Put CAPRPut 500,000 $12.0m500.0k shares New

Stakes above 5%

Companies where this manager has reported owning more than 5% of a class of shares, on Schedule 13D (may seek influence) or 13G (passive): its latest filing for each, from 19 Dec 2024 on. The largest 25 of 38.

CompanyTickerStakeChange ScheduleLast filed
ADAGIO MED HLDGS INC ADGM · 13G · filed 2026-05-15 ADGM 55.4%≈ $8.8m -2.1 pts 13G 2026-05-15
LEONABIO INC LONA · 13D · filed 2026-10-26 LONA 20.0%≈ $17.4m no change 13D 2026-10-26
LYRA THERAPEUTICS INC LYRA · 13D · filed 2025-08-14 LYRA 15.6% 13D 2025-08-14
MEIRAGTX HLDGS PLC MGTX · 13D · filed 2026-04-24 MGTX 12.6%≈ $158.6m -0.3 pts 13D 2026-04-24
SOLID BIOSCIENCES INC SLDB · 13D · filed 2026-08-14 SLDB 11.2%≈ $120.3m -1.7 pts 13D 2026-08-14
PERCEPTIVE CAP SOLUTIONS COR FRNM · 13G · filed 2026-07-23 FRNM 10.1% new 13G 2026-07-23
INHIBRX BIOSCIENCES INC INBX · 13G · filed 2026-08-14 INBX 10.0%≈ $141.1m no change 13G 2026-08-14
ALTO NEUROSCIENCE INC ANRO · 13G · filed 2026-08-14 ANRO 10.0%≈ $110.2m no change 13G 2026-08-14
OPUS GENETICS INC IRD · 13G · filed 2026-08-14 IRD 10.0%≈ $37.6m no change 13G 2026-08-14
ENGENE HOLDINGS INC 13G · filed 2026-08-14 10.0% no change 13G 2026-08-14
KIORA PHARMACEUTICALS INC KPRX · 13G · filed 2026-08-10 KPRX 10.0%≈ $1.2m new 13G 2026-08-10
ENVVENO MEDICAL CORPORATION 13G · filed 2026-02-17 10.0% 13G 2026-02-17
ORCHESTRA BIOMED HLDGS INC OBIO · 13G · filed 2025-11-14 OBIO 10.0%≈ $24.5m 13G 2025-11-14
TRINITY BIOTECH PLC 13D · filed 2026-05-04 9.9% no change 13D 2026-05-04
OUTSET MED INC OM · 13G · filed 2025-02-28 OM 9.5% new 13G 2025-02-28
NAUTILUS BIOTECHNOLOGY INC NAUT · 13D · filed 2026-08-14 NAUT 9.1%≈ $21.8m -1.0 pts 13D 2026-08-14
KARDIGAN INC KARD · 13D · filed 2026-10-01 KARD 8.8%≈ $196.9m -0.1 pts 13D 2026-10-01
QUINCE THERAPEUTICS INC IRLA · 13G · filed 2026-10-14 IRLA 8.4%≈ $1.7m new 13G 2026-10-14
RESEARCH ALLIANCE CORP III RACC · 13G · filed 2026-05-28 RACC 8.2%≈ $8.0m new 13G 2026-05-28
X4 PHARMACEUTICALS INC XFOR · 13G · filed 2026-08-14 XFOR 8.1%≈ $37.8m +0.8 pts 13G 2026-08-14
SUTRO BIOPHARMA INC STRO · 13G · filed 2026-08-14 STRO 7.9%≈ $43.3m +2.5 pts 13G 2026-08-14
PALISADE BIO INC PALI · 13G · filed 2026-05-15 PALI 7.9%≈ $29.5m -2.1 pts 13G 2026-05-15
IMMATICS N.V IMTX · 13D · filed 2026-08-27 IMTX 7.6%≈ $113.5m 13D 2026-08-27
AMYLYX PHARMACEUTICALS INC AMLX · 13G · filed 2026-05-15 AMLX 7.5%≈ $148.8m -0.7 pts 13G 2026-05-15
SAB BIOTHERAPEUTICS INC SABS · 13G · filed 2026-08-14 SABS 7.3%≈ $25.8m -1.1 pts 13G 2026-08-14

Trades reported as a company insider since 1 Apr 2026

Owning 10% or more of a company, or having someone on its board, makes this manager an insider there: it reports its trades in that company's shares on Form 4 within two business days. Open-market and private purchases and sales only.

DateCompanyTickerTradeShares ValueTheir holding
2026-08-26 IMMATICS N.V Director · See Footnote IMTX Bought 863,060 $7.5m863.1k shares +8%